Is the Achilles’ Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling?

Ivan V. Litvinov(University of Ottawa), John T. Isaacs(Brady (Norway))

The Journal of Clinical Endocrinology & Metabolism

July 1, 2003

10.1210/jc.2002-022038

Cited by 211

Related Papers

The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells

|Cancer Research|2008|233

Loss of Androgen Receptor-Dependent Growth Suppression by Prostate Cancer Cells Can Occur Independently from Acquiring Oncogenic Addiction to Androgen Receptor Signaling

|PLoS ONE|2010|37

A study of meiomitosis and novel pathways of genomic instability in cutaneous T-cell lymphomas (CTCL)

|Oncotarget|2018|25